RM1GM148766
Project Grant
Overview
Grant Description
National Resource for Advanced NMR Technology - Nuclear Magnetic Resonance (NMR) spectroscopy is a unique set of experimental tools for understanding the intricacies of biology, from macromolecular complexes to complex mixtures, from atomic resolution structure to dynamics on timescales of picoseconds to seconds, from chemistry to functional mechanisms and kinetic processes. No other technology has such breadth and potential for basic and applied research and for interfacing with other technologies, such as X-ray crystallography, small angle X-ray scattering, cryo-EM, mass spectrometry, and many other spectroscopic and analytical tools.
Structural characterization serves as the framework for using NMR to understand biological activities, protein-protein and protein interface interactions, functional mechanisms, and kinetic models. Dynamics can be exceptionally well characterized by NMR, which can lead to detailed understanding about how proteins and other macromolecules function, how complexes are formed, and how certain kinetic processes and rates are achieved. The solution NMR spectroscopy of complex mixtures is particularly useful in combination with mass spectrometry for metabolomics and other complex mixtures, whereas solid-state NMR (SSNMR) is uniquely capable of measuring chemical shift and quadrupolar tensors to provide insights into chemical biology.
Here, we focus on the frontiers of NMR technology made possible by recent breakthroughs in materials research and instrumentation, and their implementation for a broad user community pursuing fundamental questions at atomic resolution at the forefront of biomedical research.
Three technology development projects (TDP) advance the sensitivity of NMR, each featuring novel technologies. TDP1 features the use of high temperature superconductors (HTS) for RF coils, leading to high sensitivity for solution NMR spectroscopy. TDP2 takes advantage of our 600 MHz MAS-DNP NMR instrument, which will provide enhanced sensitivity through the transfer of magnetization from electrons to protons. New and much more robust DNP probes with expanded temperature ranges will be developed. TDP3 uses the 36 T series connected hybrid (36T-SCH) and all-HTS 32 T superconducting (32T-SCM) magnets for SSNMR and solution NMR spectroscopy – the 36T-SCH is the highest-field NMR spectrometer in the world, and the 32T-SCM will be the highest-field spectrometer with low-temperature (4-30 K) capabilities for NMR explorations of biosolids. These platforms will lead to dramatic enhancements in sensitivity and spectacular reductions in signal averaging times.
The science will be driven by a select team of ten scientists with driving biomedical projects (DBP), and over 30 collaborative and service projects (CSP) and technology partnership projects (TPP) that span a very broad range of biomedical and biochemical research areas. A major team effort will be placed on training a new generation of NMR users through annual workshops, as well as dissemination through publications and presentations at meetings, a wide variety of scientific organizations, news media, a dedicated website for this resource, training and educational activities, and posting of training lectures and videos of demonstrations.
Structural characterization serves as the framework for using NMR to understand biological activities, protein-protein and protein interface interactions, functional mechanisms, and kinetic models. Dynamics can be exceptionally well characterized by NMR, which can lead to detailed understanding about how proteins and other macromolecules function, how complexes are formed, and how certain kinetic processes and rates are achieved. The solution NMR spectroscopy of complex mixtures is particularly useful in combination with mass spectrometry for metabolomics and other complex mixtures, whereas solid-state NMR (SSNMR) is uniquely capable of measuring chemical shift and quadrupolar tensors to provide insights into chemical biology.
Here, we focus on the frontiers of NMR technology made possible by recent breakthroughs in materials research and instrumentation, and their implementation for a broad user community pursuing fundamental questions at atomic resolution at the forefront of biomedical research.
Three technology development projects (TDP) advance the sensitivity of NMR, each featuring novel technologies. TDP1 features the use of high temperature superconductors (HTS) for RF coils, leading to high sensitivity for solution NMR spectroscopy. TDP2 takes advantage of our 600 MHz MAS-DNP NMR instrument, which will provide enhanced sensitivity through the transfer of magnetization from electrons to protons. New and much more robust DNP probes with expanded temperature ranges will be developed. TDP3 uses the 36 T series connected hybrid (36T-SCH) and all-HTS 32 T superconducting (32T-SCM) magnets for SSNMR and solution NMR spectroscopy – the 36T-SCH is the highest-field NMR spectrometer in the world, and the 32T-SCM will be the highest-field spectrometer with low-temperature (4-30 K) capabilities for NMR explorations of biosolids. These platforms will lead to dramatic enhancements in sensitivity and spectacular reductions in signal averaging times.
The science will be driven by a select team of ten scientists with driving biomedical projects (DBP), and over 30 collaborative and service projects (CSP) and technology partnership projects (TPP) that span a very broad range of biomedical and biochemical research areas. A major team effort will be placed on training a new generation of NMR users through annual workshops, as well as dissemination through publications and presentations at meetings, a wide variety of scientific organizations, news media, a dedicated website for this resource, training and educational activities, and posting of training lectures and videos of demonstrations.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Place of Performance
Tallahassee,
Florida
323103706
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 44% from $2,689,052 to $3,867,237.
Florida State University was awarded
Advanced NMR Technology for Biomedical Research
Project Grant RM1GM148766
worth $3,867,237
from the HHS Office of the Assistant Secretary for Financial Resources in April 2023 with work to be completed primarily in Tallahassee Florida United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
4/1/23
Start Date
3/31/28
End Date
Funding Split
$3.9M
Federal Obligation
$0.0
Non-Federal Obligation
$3.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for RM1GM148766
Transaction History
Modifications to RM1GM148766
Additional Detail
Award ID FAIN
RM1GM148766
SAI Number
RM1GM148766-468609131
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75AM00 ASFR OFFICE OF THE ASSISTANT SECRETARY FOR FINANCIAL RESOURCES
Awardee UEI
JF2BLNN4PJC3
Awardee CAGE
3S772
Performance District
FL-02
Senators
Marco Rubio
Rick Scott
Rick Scott
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,344,526 | 100% |
Modified: 9/5/25